Enanta Pharmaceuticals

Enanta is a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases.

Industries

Pharmaceutical

Headquarters

Watertown, United States

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Jay R. Luly

President & CEO

Collapse

Scott T. Rottinghaus

SVP & Chief Medical Officer

Yat Sun Or

SVP, Research & Development and Chief Scientific Officer

Paul J. Mellett

SVP, Finance & Administration & Chief Financial Officer

Nathaniel S. Gardiner

SVP & General Counsel

Brendan Luu

SVP, Business Development

Tara L. Kieffer

SVP, New Product Strategy & Development

Teams

View all

Board of Directors

7 members

Leadership Team

6 members

CEO and Executive Team

5 members

Discover similar companies

Walgreens Boots Alliance

Deerfield, United States

Eli Lilly

Indianapolis, United States · Series E

Omnicell

Mountain View, United States

Alnylam Pharmaceuticals

Cambridge, United States · Post IPO Debt

Bristol-Myers Squibb

Lawrence Township, United States

AbbVie

North Chicago, United States · Series B

Prescient Healthcare Group

Jersey City, United States · Private Equity

Viatris

Pittsburgh, United States

Nano Hearing Aids

Phoenix, United States

Catalent

Franklin Township, United States · Venture

Rgenta Therapeutics

Woburn, United States · Series A

Cerevel Therapeutics

Boston, United States · Post IPO Debt

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.